164 related articles for article (PubMed ID: 31866378)
1. Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition.
Oh J; Lee BS; Lim G; Lim H; Lee CJ; Park S; Lee SH; Chung JH; Kang SM
J Mol Cell Cardiol; 2020 Jan; 138():244-255. PubMed ID: 31866378
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal shock waves protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin via the integrin-ILK-Akt-Sp1/p53 axis.
Yoon Lee J; Chung J; Hwa Kim K; Hyun An S; Yi JE; Ae Kwon K; Kwon K
Sci Rep; 2019 Aug; 9(1):12149. PubMed ID: 31434946
[TBL] [Abstract][Full Text] [Related]
3. Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of Survivin.
Lee BS; Oh J; Kang SK; Park S; Lee SH; Choi D; Chung JH; Chung YW; Kang SM
PLoS One; 2015; 10(8):e0135438. PubMed ID: 26271039
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1/p53 Signaling Pathway.
Lee JY; Chung J; Byun Y; Kim KH; An SH; Kwon K
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281156
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1.
Xia P; Chen J; Liu Y; Fletcher M; Jensen BC; Cheng Z
J Biol Chem; 2020 Mar; 295(13):4265-4276. PubMed ID: 32075913
[TBL] [Abstract][Full Text] [Related]
6. FGF-2 Transcriptionally Down-Regulates the Expression of BNIP3L via PI3K/Akt/FoxO3a Signaling and Inhibits Necrosis and Mitochondrial Dysfunction Induced by High Concentrations of Hydrogen Peroxide in H9c2 Cells.
Chen Q; Chen X; Han C; Wang Y; Huang T; Du Y; Dong Z
Cell Physiol Biochem; 2016; 40(6):1678-1691. PubMed ID: 28006775
[TBL] [Abstract][Full Text] [Related]
7. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
Venkatesan B; Prabhu SD; Venkatachalam K; Mummidi S; Valente AJ; Clark RA; Delafontaine P; Chandrasekar B
Cell Signal; 2010 May; 22(5):809-20. PubMed ID: 20074638
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes.
Altieri P; Barisione C; Lazzarini E; Garuti A; Bezante GP; Canepa M; Spallarossa P; Tocchetti CG; Bollini S; Brunelli C; Ameri P
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26746999
[TBL] [Abstract][Full Text] [Related]
10. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
[TBL] [Abstract][Full Text] [Related]
11. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
[TBL] [Abstract][Full Text] [Related]
12. Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway.
Yan F; Liu R; Zhuang X; Li R; Shi H; Gao X
J Cardiovasc Transl Res; 2021 Apr; 14(2):355-364. PubMed ID: 32671648
[TBL] [Abstract][Full Text] [Related]
13. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin protects cardiomyocytes from oxidative stress by inhibiting LOX-1 expression and cardiomyocyte apoptosis.
Zhang L; Cheng L; Wang Q; Zhou D; Wu Z; Shen L; Zhang L; Zhu J
Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):174-82. PubMed ID: 25630653
[TBL] [Abstract][Full Text] [Related]
15. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
16. FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity.
Qureshi R; Yildirim O; Gasser A; Basmadjian C; Zhao Q; Wilmet JP; Désaubry L; Nebigil CG
PLoS One; 2015; 10(11):e0141826. PubMed ID: 26536361
[TBL] [Abstract][Full Text] [Related]
17. The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity.
Lazzarini E; Balbi C; Altieri P; Pfeffer U; Gambini E; Canepa M; Varesio L; Bosco MC; Coviello D; Pompilio G; Brunelli C; Cancedda R; Ameri P; Bollini S
Sci Rep; 2016 Jul; 6():29994. PubMed ID: 27444332
[TBL] [Abstract][Full Text] [Related]
18. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
19. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin Improves Doxorubicin-Induced Cardiac Dysfunction by Modulating Hsp70, Akt, and MAPK Signaling Pathways.
Gao G; Jiang S; Ge L; Zhang S; Zhai C; Chen W; Sui S
J Cardiovasc Pharmacol; 2019 Apr; 73(4):223-231. PubMed ID: 30540688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
